$ANIK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anika Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anika Therapeutics, Inc.. Get notifications about new insider transactions in Anika Therapeutics, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 18 2006 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Option Exercise | A | 12.36 | 13,000 | 160,680 | 13,000 | |
Nov 09 2006 | ANIK | Anika Therapeutics ... | Garrison Constance H | VP Reg.,Clinical & ... | Option Exercise | A | 11.99 | 50,000 | 599,500 | 50,000 | |
Sep 12 2006 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 1.05 | 10,800 | 11,340 | 0 | |
Sep 12 2006 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 5.19 | 3,000 | 15,563 | 0 | |
Sep 12 2006 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 13.76 | 13,300 | 182,981 | 10,000 | 23.3 K to 10 K (-57.08 %) |
Sep 12 2006 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 1.05 | 10,800 | 11,340 | 23,300 | 12.5 K to 23.3 K (+86.40 %) |
Sep 12 2006 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 5.19 | 3,000 | 15,563 | 12,500 | 9.5 K to 12.5 K (+31.58 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Gift | G | 0.00 | 13,970 | 0 | 18,000 | 32 K to 18 K (-43.70 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.94 | 223 | 2,886 | 30,000 | 30.2 K to 30 K (-0.74 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 13.00 | 2,200 | 28,600 | 30,223 | 32.4 K to 30.2 K (-6.79 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 13.01 | 800 | 10,408 | 32,423 | 33.2 K to 32.4 K (-2.41 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.98 | 1,000 | 12,980 | 33,223 | 34.2 K to 33.2 K (-2.92 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.82 | 270 | 3,461 | 34,223 | 34.5 K to 34.2 K (-0.78 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.83 | 200 | 2,566 | 34,493 | 34.7 K to 34.5 K (-0.58 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.85 | 200 | 2,570 | 34,693 | 34.9 K to 34.7 K (-0.57 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.90 | 100 | 1,290 | 34,893 | 35 K to 34.9 K (-0.29 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.87 | 100 | 1,287 | 34,993 | 35.1 K to 35 K (-0.28 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.93 | 1,130 | 14,611 | 35,093 | 36.2 K to 35.1 K (-3.12 %) |
Aug 31 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 12.95 | 1,950 | 25,253 | 36,223 | 38.2 K to 36.2 K (-5.11 %) |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 0.91 | 6,750 | 6,117 | 0 | |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 9.75 | 1,596 | 15,561 | 0 | |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 5.19 | 3,000 | 15,563 | 0 | |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 7.63 | 2,000 | 15,250 | 0 | |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 13.00 | 1,827 | 23,751 | 38,173 | 40 K to 38.2 K (-4.57 %) |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 13.00 | 3,346 | 43,498 | 40,000 | 43.3 K to 40 K (-7.72 %) |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 0.91 | 6,750 | 6,117 | 43,346 | 36.6 K to 43.3 K (+18.44 %) |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 9.75 | 1,596 | 15,561 | 36,596 | 35 K to 36.6 K (+4.56 %) |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 5.19 | 3,000 | 15,563 | 35,000 | 32 K to 35 K (+9.38 %) |
Aug 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 7.63 | 2,000 | 15,250 | 32,000 | 30 K to 32 K (+6.67 %) |
Aug 29 2006 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 13.00 | 15,500 | 201,500 | 31,970 | 47.5 K to 32 K (-32.65 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Option Exercise | M | 0.90 | 25,000 | 22,500 | 0 | |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Option Exercise | M | 1.23 | 6,000 | 7,380 | 0 | |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.72 | 4,911 | 57,557 | 0 | 4.9 K to 0 (-100.00 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.70 | 10,000 | 117,000 | 4,911 | 14.9 K to 4.9 K (-67.06 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.69 | 1,070 | 12,508 | 14,911 | 16 K to 14.9 K (-6.70 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.67 | 500 | 5,835 | 15,981 | 16.5 K to 16 K (-3.03 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.66 | 200 | 2,332 | 16,481 | 16.7 K to 16.5 K (-1.20 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.65 | 2,449 | 28,531 | 16,681 | 19.1 K to 16.7 K (-12.80 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.62 | 100 | 1,162 | 19,130 | 19.2 K to 19.1 K (-0.52 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.61 | 200 | 2,322 | 19,230 | 19.4 K to 19.2 K (-1.03 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.60 | 1,800 | 20,880 | 19,430 | 21.2 K to 19.4 K (-8.48 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.56 | 100 | 1,156 | 21,230 | 21.3 K to 21.2 K (-0.47 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.55 | 400 | 4,620 | 21,330 | 21.7 K to 21.3 K (-1.84 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.51 | 879 | 10,117 | 21,730 | 22.6 K to 21.7 K (-3.89 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.50 | 740 | 8,510 | 22,609 | 23.3 K to 22.6 K (-3.17 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.62 | 200 | 2,324 | 23,349 | 23.5 K to 23.3 K (-0.85 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.61 | 200 | 2,322 | 23,549 | 23.7 K to 23.5 K (-0.84 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.55 | 601 | 6,942 | 23,749 | 24.4 K to 23.7 K (-2.47 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.60 | 1,650 | 19,140 | 24,350 | 26 K to 24.4 K (-6.35 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.65 | 3,000 | 34,950 | 26,000 | 29 K to 26 K (-10.34 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 11.70 | 2,000 | 23,400 | 29,000 | 31 K to 29 K (-6.45 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Buy | M | 0.90 | 25,000 | 22,500 | 31,000 | 6 K to 31 K (+416.67 %) |
Jul 31 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Buy | M | 1.23 | 6,000 | 7,380 | 6,000 | 0 to 6 K |
Jan 30 2006 | ANIK | Anika Therapeutics ... | Toth Carol A | VP, Research and De ... | Option Exercise | A | 10.51 | 13,000 | 136,630 | 13,000 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Option Exercise | A | 10.51 | 1,770 | 18,603 | 1,770 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | A | 10.51 | 1,770 | 18,603 | 1,770 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | A | 10.51 | 1,770 | 18,603 | 1,770 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | A | 10.51 | 1,770 | 18,603 | 1,770 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President, Ope ... | Option Exercise | A | 10.51 | 13,000 | 136,630 | 13,000 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.51 | 49,000 | 514,990 | 49,000 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | A | 10.51 | 1,770 | 18,603 | 1,770 | |
Jan 30 2006 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Option Exercise | A | 10.51 | 6,500 | 68,315 | 6,500 | |
Jan 26 2006 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Option Exercise | A | 10.50 | 4,500 | 47,250 | 4,500 | |
Jan 26 2006 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | A | 14.33 | 1,275 | 18,271 | 1,275 | |
Jan 26 2006 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | D | 14.33 | 1,275 | 18,271 | 0 | |
Oct 25 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 3.13 | 4,500 | 14,063 | 0 | |
Oct 25 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 3.13 | 10,000 | 31,250 | 0 | |
Oct 25 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 11.80 | 12,500 | 147,500 | 9,500 | 22 K to 9.5 K (-56.82 %) |
Oct 25 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 3.13 | 4,500 | 14,063 | 22,000 | 17.5 K to 22 K (+25.71 %) |
Oct 25 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 3.13 | 10,000 | 31,250 | 17,500 | 7.5 K to 17.5 K (+133.33 %) |
Oct 04 2005 | ANIK | Anika Therapeutics ... | Litman Peter | VP, Business Develo ... | Option Exercise | A | 11.85 | 100,000 | 1,185,000 | 100,000 | |
Jul 13 2005 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Option Exercise | A | 11.24 | 75,000 | 843,000 | 75,000 | |
Jun 07 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.20 | 2,000 | 28,400 | 47,470 | 49.5 K to 47.5 K (-4.04 %) |
Jun 07 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.17 | 2,400 | 33,996 | 49,470 | 51.9 K to 49.5 K (-4.63 %) |
Jun 06 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.30 | 1,600 | 22,880 | 51,870 | 53.5 K to 51.9 K (-2.99 %) |
Jun 06 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.20 | 2,000 | 28,401 | 53,470 | 55.5 K to 53.5 K (-3.61 %) |
Jun 06 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.40 | 2,000 | 28,800 | 55,470 | 57.5 K to 55.5 K (-3.48 %) |
Jun 06 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.45 | 1,200 | 17,340 | 57,470 | 58.7 K to 57.5 K (-2.05 %) |
Jun 06 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.48 | 1,800 | 26,064 | 58,670 | 60.5 K to 58.7 K (-2.98 %) |
Jun 06 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.58 | 3,000 | 43,740 | 60,470 | 63.5 K to 60.5 K (-4.73 %) |
Jun 06 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 14.50 | 4,000 | 58,000 | 63,470 | 67.5 K to 63.5 K (-5.93 %) |
Jun 03 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | M | 3.13 | 10,000 | 31,250 | 0 | |
Jun 03 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Buy | M | 3.13 | 10,000 | 31,250 | 67,470 | 57.5 K to 67.5 K (+17.40 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 3.13 | 10,000 | 31,250 | 0 | |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.00 | 7,500 | 112,500 | 30,000 | 37.5 K to 30 K (-20.00 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.01 | 63 | 946 | 37,500 | 37.6 K to 37.5 K (-0.17 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.03 | 100 | 1,503 | 37,563 | 37.7 K to 37.6 K (-0.27 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.09 | 100 | 1,509 | 37,663 | 37.8 K to 37.7 K (-0.26 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.10 | 1,037 | 15,659 | 37,763 | 38.8 K to 37.8 K (-2.67 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.11 | 100 | 1,511 | 38,800 | 38.9 K to 38.8 K (-0.26 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.12 | 600 | 9,072 | 38,900 | 39.5 K to 38.9 K (-1.52 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.13 | 100 | 1,513 | 39,500 | 39.6 K to 39.5 K (-0.25 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.14 | 200 | 3,028 | 39,600 | 39.8 K to 39.6 K (-0.50 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 15.16 | 200 | 3,032 | 39,800 | 40 K to 39.8 K (-0.50 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 3.13 | 10,000 | 31,250 | 40,000 | 30 K to 40 K (+33.33 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | M | 0.91 | 13,500 | 12,234 | 0 | |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.70 | 1,000 | 14,700 | 7,500 | 8.5 K to 7.5 K (-11.76 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.68 | 2,000 | 29,360 | 8,500 | 10.5 K to 8.5 K (-19.05 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.67 | 2,100 | 30,807 | 10,500 | 12.6 K to 10.5 K (-16.67 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.66 | 1,900 | 27,854 | 12,600 | 14.5 K to 12.6 K (-13.10 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.65 | 700 | 10,255 | 14,500 | 15.2 K to 14.5 K (-4.61 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.64 | 800 | 11,712 | 15,200 | 16 K to 15.2 K (-5.00 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.63 | 675 | 9,875 | 16,000 | 16.7 K to 16 K (-4.05 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Sell | S | 14.62 | 825 | 12,062 | 16,675 | 17.5 K to 16.7 K (-4.71 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Buy | M | 0.91 | 13,500 | 12,234 | 17,500 | 4 K to 17.5 K (+337.50 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 3.13 | 10,000 | 31,250 | 0 | |
May 27 2005 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Sell | S | 14.52 | 300 | 4,356 | 58,920 | 59.2 K to 58.9 K (-0.51 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Sell | S | 14.51 | 100 | 1,451 | 59,220 | 59.3 K to 59.2 K (-0.17 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Sell | S | 14.50 | 1,760 | 25,520 | 59,320 | 61.1 K to 59.3 K (-2.88 %) |
May 27 2005 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Buy | M | 3.13 | 10,000 | 31,250 | 61,080 | 51.1 K to 61.1 K (+19.58 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Option Exercise | M | 1.75 | 23,000 | 40,250 | 0 | |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.05 | 3,460 | 52,073 | 0 | 3.5 K to 0 (-100.00 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.60 | 2,840 | 44,304 | 3,460 | 6.3 K to 3.5 K (-45.08 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.61 | 821 | 12,816 | 6,300 | 7.1 K to 6.3 K (-11.53 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.65 | 4,400 | 68,860 | 7,121 | 11.5 K to 7.1 K (-38.19 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.66 | 600 | 9,396 | 11,521 | 12.1 K to 11.5 K (-4.95 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.67 | 500 | 7,835 | 12,121 | 12.6 K to 12.1 K (-3.96 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.70 | 3,000 | 47,100 | 12,621 | 15.6 K to 12.6 K (-19.20 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.71 | 1,279 | 20,093 | 15,621 | 16.9 K to 15.6 K (-7.57 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 15.75 | 600 | 9,450 | 16,900 | 17.5 K to 16.9 K (-3.43 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Sell | S | 16.00 | 5,500 | 88,000 | 17,500 | 23 K to 17.5 K (-23.91 %) |
May 24 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Buy | M | 1.75 | 23,000 | 40,250 | 23,000 | 0 to 23 K |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Option Exercise | M | 1.75 | 4,000 | 7,000 | 0 | |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Option Exercise | M | 1.75 | 24,600 | 43,050 | 4,000 | |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Option Exercise | M | 1.75 | 1,400 | 2,450 | 28,600 | |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 15.25 | 4,000 | 61,000 | 0 | 4 K to 0 (-100.00 %) |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.75 | 4,000 | 7,000 | 4,000 | 0 to 4 K |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 15.50 | 13,100 | 203,050 | 0 | 13.1 K to 0 (-100.00 %) |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 15.53 | 5,000 | 77,650 | 13,100 | 18.1 K to 13.1 K (-27.62 %) |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 15.54 | 3,000 | 46,620 | 18,100 | 21.1 K to 18.1 K (-14.22 %) |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 15.67 | 3,500 | 54,845 | 21,100 | 24.6 K to 21.1 K (-14.23 %) |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.75 | 24,600 | 43,050 | 24,600 | 0 to 24.6 K |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 15.75 | 1,400 | 22,050 | 0 | 1.4 K to 0 (-100.00 %) |
May 20 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.75 | 1,400 | 2,450 | 1,400 | 0 to 1.4 K |
Apr 27 2005 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | A | 14.33 | 1,275 | 18,271 | 1,275 | |
Apr 27 2005 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | A | 14.33 | 1,275 | 18,271 | 1,275 | |
Apr 27 2005 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | A | 14.33 | 1,275 | 18,271 | 1,275 | |
Apr 27 2005 | ANIK | Anika Therapeutics ... | SADOW HARVEY S | Director | Option Exercise | A | 14.33 | 1,275 | 18,271 | 1,275 | |
Apr 27 2005 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | A | 14.33 | 1,275 | 18,271 | 1,275 | |
Feb 14 2005 | ANIK | Anika Therapeutics ... | ONeill James E | Chief Accounting Of ... | Option Exercise | A | 8.71 | 6,000 | 52,260 | 6,000 | |
Feb 14 2005 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and President | Option Exercise | A | 8.71 | 50,000 | 435,500 | 50,000 | |
Feb 14 2005 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President, Ope ... | Option Exercise | A | 8.71 | 50,000 | 435,500 | 50,000 | |
Nov 23 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.62 | 13,300 | 127,942 | 0 | 13.3 K to 0 (-100.00 %) |
Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 0.99 | 12,500 | 12,375 | 0 | |
Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 0.91 | 13,500 | 12,234 | 0 | |
Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Option Exercise | M | 3.13 | 10,000 | 31,250 | 0 | |
Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.63 | 22,700 | 218,601 | 13,300 | 36 K to 13.3 K (-63.06 %) |
Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 0.99 | 12,500 | 12,375 | 36,000 | 23.5 K to 36 K (+53.19 %) |
Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Buy | M | 0.91 | 13,500 | 12,234 | 23,500 | 10 K to 23.5 K (+135.00 %) |
Nov 19 2004 | ANIK | Anika Therapeutics ... | MCKAY SAMUEL F | Director | Sell | S | 9.59 | 9,000 | 86,270 | 10,000 | 19 K to 10 K (-47.37 %) |